Articles Archives - Page 225 of 733

ThursdayNov 10, 2022 11:15 am

Specialized Market Lender REZYFi, Inc. Believes They Have Real Opportunity Amid Challenges Faced by Traditional Lenders

While economies worldwide are struggling to control spiking inflation rates, REZYFi, a mortgage lender servicing non-traditional as well as other loans, sees unique financial opportunities Through the use of proprietary automated machine learning and associated technologies, together with preparations to launch a high-margin cannabis division later this year to serve an industry in need of loan origination options, REZYFi is working to grow its operation RZFI is licensed in more than 30 U.S. states and expects to expand its loan origination services to all remaining states in coming months Economic challenges resulting from governmental efforts to tame inflation could in…

ThursdayNov 10, 2022 10:30 am

As World Pollutant Concerns Grow, Correlate Infrastructure Partners Inc. (CIPI) Helps Drive Optimism for Affordable and Effective ESG Solutions

Climate change and industrialized pollution emissions continue to raise warnings worldwide that the quality of human life is being compromised U.S.-based Correlate Infrastructure Partners is working to establish solutions for its clients by assessing utilities inefficiencies, advising on affordable improvements, and then helping to successfully implement changes through access to highly cost-effective financing opportunities The federal government’s recent passage of greenhouse gas reduction financing opportunities through the Inflation Reduction Act (“IRA”) has established the government as a ready partner in companies’ ESG policies The IRA has become particularly attractive to public, non-profit, and REIT entities because of changes to subsidy…

ThursdayNov 10, 2022 9:45 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Offers Fully Compliant Data Solutions, CPRA Data Law Set to Take Effect on January 1, 2023

The CCPA limits data flows to brands and marketers, and CPRA amendments are set to take effect January 1, 2023 CPRA and CCPA provisions include the right to opt-out of data sharing and sale, as well as the right to data deletion Consumer data is critical to branding and advertising strategies Reklaim provides an ecosystem that equips marketers with fully compliant, consumer-verified data sets while rewarding consumers for sharing information With the aim of protecting consumers, the California Consumer Privacy Act (“CCPA”) and amendments provided by the California Privacy Rights Act (“CPRA”) are gradually transforming the advertising landscape by limiting…

ThursdayNov 10, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Maintains Strong Cash Position as It Continues Drug Development Program Pursuing Treatment for GBM

CNS Pharmaceuticals is focused on advancing its clinical development for the Berubicin drug candidate in order to bring meaningful treatment to GBM patients GBM, which has a low survival rate, has limited treatment options when it progresses after first-line therapy The company is looking to find a solution with Berubicin and is currently evaluating this drug candidate in a potentially pivotal global study CNS’s ongoing R&D efforts are boosted by its strong cash position; in its Q2 2022 report, the company announced it had cash of about $9.0 million and working capital of $10.5 million CNS Pharmaceuticals (NASDAQ: CNSP), an…

WednesdayNov 09, 2022 11:15 am

With the World’s Attention on COP27, GeoSolar Technologies Inc.’s Solutions Gain Greater Relevance Than Ever Before

The upcoming COP27 Conference in Egypt will dictate the world’s latest measures designed to adhere to 2015’s Paris Agreement With the world increasingly focused on containing global warming and subduing household greenhouse gas emissions, has taken on increasing relevance Within the U.S., households account for 20% of total carbon emissions – with U.S. household emissions alone surpassing those of Germany as a whole GeoSolar Technologies’ revolutionary SmartGreen(TM) Home system has been designed to power homes through a mix of renewable energy sources – effectively reducing the average home’s carbon footprint to near zero When the upcoming United Nation’s Climate Change…

WednesdayNov 09, 2022 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Offers Cloud-Based Technology Solutions to Simplify Over-The-Road Trade Avenues Across USMCA Marketplace

The United States is still the world's largest economy and largest importer and exporter of goods and services – with strong ties to Mexico and Canada Mexico has reached number one as a US trade partner, with a value of $520.12 billion during the first eight months of 2022, followed by Canada Freight Technologies’ cloud-based marketplace, Fr8App, is simplifying Over-The-Road (“OTR”) trade and reducing the carbon footprint in the industry by directly matching OTR shippers with qualified carriers and provides 24/7 live tracking, quick pay, and driver rating features The company is building strategic relationships with key customers across trade…

WednesdayNov 09, 2022 9:45 am

Odyssey Health, Inc.’s (ODYY) PRV-002 Drug Candidate Poised to Potentially Reduce Long-Term Risks Associated with Concussion

Odyssey Health is a medical company specializing in the development of unique, life-saving medical products that provide solutions to unmet clinical needs, one of which is concussion, which currently does not have an FDA-approved drug The company has developed the PRV-002 drug candidate, which is designed to be administered intranasally where pre-clinical results have shown to be effective in treating a concussion within 30 minutes of administration Through its drug candidate, Odyssey hopes to reduce the risks and potential for long-term consequences associated with concussions Up until Olympic gold medalist Katie Weatherston was forced into retirement following a series of…

WednesdayNov 09, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Defines Path to Profitability and Portfolio Expansion with Proposed Franchise Global Health Inc. Acquisition

Flora Growth signed a definitive agreement with FGH to acquire 100% of all issued and outstanding shares by way of a statutory plan of agreement The deal is expected to close in December following the presentation of the agreement to shareholders; the acquisition will open Flora to the German and EU medical markets, increasing the company’s international revenue and providing essential distribution to German pharmacies and a growing wholesale market FGH’s acquisition adds to Flora’s expanding list of subsidiaries which currently comprise Vessel Brand Inc. and JustCBD, among others, and it is expected to deliver at least $3 million in…

TuesdayNov 08, 2022 11:15 am

REZYFi, Inc. Leverages Cannabis Industry Interests to Diversify Banking and Real Estate as DCC Prioritizes Research Project Funding

The California Department of Cannabis Control (“DCC”) has reserved $20 million in funding for research prioritizing cannabis projects, including potency, health impact, medicinal use, legacy cannabis genetics, and industry health The medicinal and recreational cannabis market size in the US is anticipated to reach $33 billion in 2022, with a revenue outlook of $52.6 billion by 2026 REZYFi Inc., through two wholly-owned subsidiaries, is positioned to be the first cannabis mortgage banker in the United States The state of California Department of Cannabis Control has reserved $20 million in funding for research that prioritizes numerous cannabis topics, including potency, health…

TuesdayNov 08, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Aiming to Address Unmet Patient Needs of Hypertensive Patients

Lexaria just completed its HYPER-H21-4 human clinical hypertension study, posting a sustained drop in blood pressure in normally active hypertensive patients With the success of this study, the company is working towards an IND application to seek FDA approval for its patented DehydraTECH(TM)-enabled CBD capsule formulation. 47% of adults live with hypertension but only 24% of them have it under control With its DehydraTECH-CBD, Lexaria hopes to not only address the severe unmet patient need associated with hypertension but also tap into a market that is set to be valued at $34 billion by 2030 Lexaria Bioscience (NASDAQ: LEXX), a…

Site Search

Company Search

Category: Articles